Removal and restoration of epithelial chloride secretory activity of kinins by gene manipulation.
Kinins are known to stimulate electrogenic chloride secretion in many mammalian epithelia, including those of the airways and the alimentary tract. In this study the chloride secretory activity of lysylbradykinin (LBK) on murine colonic epithelium has been examined, specifically to discover the primary and final effector mechanisms in this process, i.e., which kinin receptors are involved and which chloride channels are responsible for chloride secretion. The approach used was to modify the mice genetically and assess the effects on kinin mediated chloride secretion using voltage clamping at zero potential. Briefly, LBK increased SCC in mouse colon by approximately 150 microA cm-2 with an EC50 of approximately 5 nM. In null CF mice LBK, 1 microM had no effect on chloride secretion, but reduced SCC due to K+ secretion. This effect is normally masked in wild-type tissues by dominant chloride secretion, but can be shown to occur to the same extent by measuring K+ secretion with radioisotopes. Null CF mice produce no cftr, but CFTR was introduced into CF mice by injecting a YAC containing the human CF gene into the pronucleus of CF zygotes. Colonic epithelia from mice with the incorporated YAC showed the same sensitivity to LBK as wild-type tissues and achieved the same maximal chloride secretory response. Colonic epithelia from mice in which the B2r gene had been disrupted showed no response to LBK at normally supramaximally effective concentrations, although responses to other secretagogues were normal. Similarly des-Arg-BK caused no acute chloride secretory response in colonic epithelia from B2 knockout mice, however small responses appeared if tissues were incubated in vitro for 3-6 h. It is concluded that cftr chloride channels and B2rs are required for electrogenic chloride secretion. Further CFTR can replace cftr with no effect on either the sensitivity or extent of chloride secretion. In vitro, colonic epithelia may generate B1rs which, upon activation, have a minor effect on chloride secretory activity.
Cuthbert
A
A
Department of Pharmacology, University of Cambridge, UK.
Huxley
C
C
Hess
J F
JF
D000818:Animals; D001920:Bradykinin / Q000031:analogs & derivatives / Q000494:pharmacology; D002712:Chlorides / Q000378:metabolism*; D018244:Chromosomes, Artificial, Yeast / Q000235:genetics; D003106:Colon / Q000187:drug effects / Q000378:metabolism; D003550:Cystic Fibrosis / Q000235:genetics / Q000378:metabolism; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D017136:Ion Transport / Q000187:drug effects; D007609:Kallidin / Q000494:pharmacology; D007705:Kinins / Q000494:pharmacology*; D051379:Mice; D008822:Mice, Transgenic; D043783:Receptor, Bradykinin B1; D018002:Receptors, Bradykinin / Q000819:agonists
C505032:CFTR protein, human; D002712:Chlorides; D007705:Kinins; D043783:Receptor, Bradykinin B1; D018002:Receptors, Bradykinin; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C024626:bradykinin, des-Arg(9)-; D007609:Kallidin; D001920:Bradykinin